CSF1 and ovarian cancer: Importantly, an increased number and activity of NK cells were previously detected in human patients receiving M‐CSF (under the name Mirimostim) to correct severe myelosuppression induced by chemotherapy for ovarian cancer (Hidaka et al, 2003), suggesting that M‐CSF reproduces in humans the effect depicted in mice.